Australia declared a national priority to produce mRNA vaccines © Getty Images
Australia declared a national priority to produce mRNA vaccines © Getty Images

Victoria plans $50m mRNA vaccine manufacturing plant

26 April 2021

The Victorian state government is set to invest $50m in new mRNA pharmaceutical manufacturing facilities to help Australia gain an independent supply of drugs like the Pfizer and Moderna vaccines.

The state is planning to invest in research and manufacturing technology in Melbourne after Australia declared a national priority to produce mRNA vaccines to reduce dependence on outside suppliers.

 Want to stay up to date with the news? Sign up to our daily bulletin.

To read the rest of this article you need to sign in:
Don't have an account? Register here

JOIN CIPS

Not a CIPS member? Why not join CIPS to access a full range of benefits, including:

  • Access all areas of the CIPS Knowledge on-line library including tools and templates and Supply Management stories.
  • Enhance your network and get connected to a global community of 120,000 in 150 countries.
  • Stay in touch and up to date through member only events and branch meetings.
  • Annual subscription to Supply Management magazine.
  • 10 per cent discount on all training courses, workshops, seminars and conferences.
  • Up to 15 per cent discount on books from the CIPS book store, including course books and a range of further reading text books.

And much more. Click here to join >

LATEST
JOBS
All Offices
Competitive salary
Browne Jacobson
Cheshire Police Headquarters, Winsford, Cheshire
Up to £47,000 per annum + pension, flexi working scheme, car share and agile working options
Cheshire Constabulary
SEARCH JOBS
CIPS Knowledge
Find out more with CIPS Knowledge:
  • best practice insights
  • guidance
  • tools and templates
GO TO CIPS KNOWLEDGE